Gefitinib is a tyrosine kinase inhibitor used for non-small cell lung cancer treatment by inhibiting EGFR. It is grouped under the following drug class(es): Antineoplastic agents, Kinase inhibitors and Tyrosine Kinase Inhibitors. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Iressa and Irressat. Its PubChem CID is 123631.
Gefitinib
| CAS No | 184475-35-2 |
|---|---|
| Molecular Formula | C22H24ClFNO3 |
| Molecular Weight | 446.90 g/mol |
| Synonyms | N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Gefitinib is a tyrosine kinase inhibitor used for non-small cell lung cancer treatment by inhibiting EGFR. It is grouped under the following drug class(es): Antineoplastic agents, Kinase inhibitors and Tyrosine Kinase Inhibitors.
The listed CAS number is 184475-35-2.
The listed molecular formula is C22H24ClFNO3.
The listed molecular weight is 446.90 g/mol.
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine.
The source lists Iressa and Irressat.